Anticancer properties of isoniazid & hydrazine-sulphate.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D005354:Fibrosarcoma / Q000188:drug therapy*; D006834:Hydrazines / Q000627:therapeutic use*; D007538:Isoniazid / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy
D006834:Hydrazines; D007538:Isoniazid